Philips (NYSE:PHG) has issued corrections for some of its Trilogy Evo ventilator platforms due to multiple issues.
(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...
On Tuesday, Koninklijke Philips N.V. (NYSE:PHG) issued a correction related to the Software Version used in Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal ventilators to resolve ...
Philips has issued a voluntary recall of software for its Trilogy Evo ventilator series and a warning to patients not to use non-pneumatic nebulizers with the devices, as they may not deliver the ...
The use of in-line nebulizers placed in certain locations may lead to aerosol deposits forming over time on the ventilator flow sensor. Should this occur, there is a possibility of inaccurate flow ...
Royal Philips NV has warned that some of its ventilators can malfunction with a sudden loss of power, the latest in a series of product safety issues plaguing the company. The medical equipment ...
Murraysville, Pa.-based Philips Respironics has issued a worldwide recall of its Trilogy Ventilators Models 100, 200 and 202 due to a potentially faulty component on the ventilators’ power boards. The ...
Philips has issued a correction for Trilogy Evo Platform Ventilators, according to the U.S. Food and Drug Administration (FDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results